stars 1 stars 2 stars 3

With a background of 10 years in venom research, BioConus is specialised in extracting pure venoms from live marine cone snails. * www.bioconus.com * BioConus offers lyophilised venoms from 4 different Conus species: • Conus textile • Conus victoriae • Conus imperialis • Conus striatus Cone snail venoms are natural libraries composed of hundreds of bioactive compounds, also called conopeptides. Conopeptides are small peptides (10-30 amino acids) with selectivity and high-affinity properties for many human receptors and may be used in pharmacological research (especially ion channels), for drug discovery screening and as a potential therapeutic itself. Over the last decade, several conopeptides have been identified with therapeutic potential for: • neurodegenerative diseases, • cardiovascular diseases, • cancer, • pain and inflammation.

BioConus Questions

The BioConus annual revenue was $3 million in 2026.

BioConus is based in Waterloo, New South Wales.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users